Supernus Pharmaceuticals(SUPN) - 2020 Q4 - Earnings Call Transcript

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q4 2020 Earnings Conference Call February 25, 2021 4:30 PM ET Company Participants Peter Vozzo - Westwicke Partners Jack Khattar - Founder, President, CEO, Secretary & Director James Kelly - EVP & CFO Conference Call Participants David Steinberg - Jefferies David Amsellem - Piper Sandler & Co. Nicholas Rubino - Stifel, Nicolaus & Company Operator Good afternoon, and welcome to Supernus Pharmaceuticals Fourth Quarter and Full Year 2020 Financial Results Conference ...